Chemicals · Founded 1960 · www.hoclindia.com · BSE 500449 · NSE HOCL · ISIN INE048A01011
No Notes Added Yet
Business
Hindustan Organic Chemicals Ltd. (HOCL) is a Central Public Sector Enterprise (CPSE) engaged in the manufacturing of basic and intermediate organic chemicals. Its core business involves producing essential chemical building blocks that are critical raw materials for a wide range of downstream industries. These include pharmaceuticals, agrochemicals, dyes & pigments, laminates, resins, plastics, and rubber chemicals. The company primarily generates revenue by selling these bulk organic chemicals to industrial customers across various sectors.
Revenue Mix
HOCL's operations are largely focused on a relatively concentrated portfolio of high-volume organic chemicals. Its key product categories include:
Basic Chemicals: Predominantly Phenol, Acetone, and Hydrogen Peroxide. These are high-volume commodity chemicals used extensively in various industrial applications.
Intermediates: Products such as Aniline and Nitrobenzene, which serve as crucial precursors for the synthesis of other chemicals in industries like dyes, pharmaceuticals, and rubber chemicals.
Note: Specific revenue contributions by product group are not consistently disclosed and can be highly variable due to the cyclical nature and price volatility of commodity chemicals.
Industry
HOCL operates within the Indian chemicals industry, specifically in the commodity organic chemicals segment. This segment is characterized by cyclical demand, sensitivity to global crude oil prices (for raw materials), price volatility, and significant competition from both large domestic private players and international imports. As a Public Sector Undertaking (PSU), HOCL holds a strategic position in providing foundational chemical building blocks within India, contributing to domestic supply and import substitution. While it contributes to critical industrial supply chains, it operates in a highly competitive environment where cost efficiency and scale are paramount.
MOAT
HOCL's primary advantages include:
Established Infrastructure and Scale: With a long operational history, HOCL possesses established manufacturing facilities, particularly at its Ambalamugal (Kochi) unit. This provides a foundational production capacity.
Strategic Importance (PSU): As a government-owned enterprise, HOCL has a strategic mandate to ensure domestic availability of certain critical chemicals. This can imply a degree of stability, government support, and strategic customer relationships in certain situations.
Process Expertise: Decades of experience in producing specific organic chemicals have led to accumulated operational knowledge and process know-how in its core product lines.
However, operating primarily in commodity chemicals, strong durable moats are generally challenging to maintain against global price pressures and new market entrants.
Growth Drivers
Growing Domestic Industrial Demand: India's overall economic growth, particularly in downstream manufacturing sectors (e.g., automotive, construction, pharmaceuticals, agrochemicals), drives consistent demand for HOCL's basic chemical products.
Government Initiatives: "Make in India" and import substitution policies can create a favorable environment for domestic producers of essential chemicals.
Modernization and Efficiency Improvements: Strategic investments in upgrading existing plants to enhance operational efficiency, reduce costs, and comply with evolving environmental standards could improve profitability.
Diversification into Value-Added Products: Any future strategic move into more specialty chemicals or derivatives of its current products could offer higher margins and reduce sensitivity to commodity price cycles.
Risks
Commodity Price Volatility: Fluctuations in global crude oil prices directly impact the cost of key raw materials (e.g., benzene, propylene) and, consequently, the selling prices and profitability of its finished products like phenol and acetone.
Intense Competition: The market for basic organic chemicals is highly competitive, with pressures from larger private sector players (both domestic and international) and cheaper imports, which can compress margins.
Environmental & Regulatory Risks: The chemical industry is subject to stringent environmental regulations and compliance costs. Any non-compliance can lead to penalties, operational disruptions, or increased capital expenditure.
Technological Obsolescence: Maintaining competitiveness requires continuous investment in technology. Older manufacturing processes might be less efficient or environmentally compliant, necessitating significant capital expenditure for upgrades.
Governmental Intervention and Bureaucracy: As a PSU, HOCL is subject to government directives, slower decision-making processes, and potential strategic disinvestment plans, which can introduce uncertainty and impact business agility.
Financial Health: The company has faced historical financial challenges, which remain a key monitoring factor for its long-term sustainability.
Management & Ownership
Ownership: Hindustan Organic Chemicals Ltd. (HOCL) is a Public Sector Undertaking (PSU), with the majority stake held by the Government of India through the Ministry of Chemicals and Fertilizers.
Management: The management team typically comprises professionals appointed by the government. The board often includes government nominees, executive directors, and independent directors. Being a PSU, management decisions and strategic directions can sometimes be influenced by government policies and bureaucratic processes.
Outlook
HOCL operates in a foundational segment of the Indian chemical industry, supplying essential organic chemicals critical for various industrial applications. The company stands to benefit from India's sustained industrial growth and the government's focus on domestic manufacturing and import substitution. Its established infrastructure and strategic importance as a PSU provide a degree of operational stability.
However, the outlook is moderated by the inherent volatility of the commodity chemicals business, exposing the company to significant price fluctuations in raw materials and finished goods, alongside intense competition from domestic and international players. HOCL's historical financial performance has presented challenges, and its future will largely depend on its ability to enhance operational efficiency, modernize its facilities, effectively manage commodity price risks, and potentially diversify into higher-margin products while navigating the constraints and opportunities of being a public sector enterprise. The broader trajectory of India's industrial sector and government policy towards PSUs will be crucial determinants of its long-term viability and growth.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 183 | 59 | 175 | 165 | 137 | 164 | 126 | 147 | 136 | 96 |
| Other Income | 6 | 4 | 5 | 8 | 5 | 5 | 5 | 6 | 3 | 4 |
| Total Income | 189 | 64 | 179 | 174 | 142 | 169 | 131 | 153 | 140 | 100 |
| Total Expenditure | 183 | 83 | 175 | 191 | 173 | 177 | 143 | 151 | 120 | 91 |
| Operating Profit | 6 | -19 | 5 | -18 | -31 | -8 | -12 | 2 | 20 | 9 |
| Interest | 17 | 16 | 18 | 18 | -10 | 5 | 5 | 5 | 5 | 5 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | -42 | 545 | 7 | -0 | -0 | 0 | 0 |
| Profit Before Tax | -12 | -36 | -14 | -79 | 523 | -6 | -18 | -4 | 15 | 4 |
| Provision for Tax | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | -1 | 0 |
| Profit After Tax | -12 | -36 | -14 | -79 | 520 | -6 | -18 | -4 | 16 | 4 |
| Adjustments | 0 | 0 | 0 | -0 | 0 | 0 | -0 | 0 | -0 | 0 |
| Profit After Adjustments | -12 | -35 | -14 | -79 | 520 | -6 | -18 | -4 | 16 | 4 |
| Adjusted Earnings Per Share | -1.8 | -5.3 | -2 | -11.7 | 77.3 | -0.9 | -2.7 | -0.6 | 2.3 | 0.6 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 144 | 177 | 279 | 511 | 331 | 415 | 434 | 631 | 704 | 536 | 574 | 505 |
| Other Income | 16 | 6 | 66 | 117 | 21 | 21 | 34 | 11 | 17 | 23 | 19 | 18 |
| Total Income | 160 | 183 | 345 | 628 | 353 | 437 | 467 | 642 | 721 | 559 | 593 | 524 |
| Total Expenditure | 266 | 331 | 449 | 484 | 390 | 388 | 433 | 625 | 705 | 622 | 591 | 505 |
| Operating Profit | -106 | -148 | -104 | 145 | -37 | 48 | 34 | 17 | 16 | -63 | 2 | 19 |
| Interest | 69 | 97 | 78 | 68 | 58 | 54 | 66 | 67 | 70 | 43 | 20 | 20 |
| Depreciation | 10 | 14 | 6 | 3 | 3 | 3 | 1 | 1 | 1 | 2 | 2 | 2 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 503 | 7 | 0 |
| Profit Before Tax | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -51 | -55 | 395 | -14 | -3 |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | -1 | -1 |
| Profit After Tax | -185 | -259 | -187 | 73 | -98 | -8 | -32 | -51 | -55 | 392 | -13 | -2 |
| Adjustments | 5 | 2 | 0 | -1 | 2 | 11 | -18 | -4 | 1 | 0 | 0 | 0 |
| Profit After Adjustments | -180 | -258 | -187 | 72 | -96 | 3 | -51 | -55 | -55 | 392 | -13 | -2 |
| Adjusted Earnings Per Share | -26.8 | -38.3 | -27.8 | 10.8 | -14.3 | 0.4 | -7.6 | -8.2 | -8.1 | 58.3 | -1.9 | -0.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 7% | -3% | 7% | 15% |
| Operating Profit CAGR | 0% | -51% | -47% | 0% |
| PAT CAGR | -103% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 45% | 18% | 6% | 8% |
| ROE Average | -22% | -7% | -4% | -29% |
| ROCE Average | 2% | 402% | 241% | 97% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | -764 | 119 | 34 | 111 | 17 | 32 | -5 | -50 | -51 | 1045 | 1031 |
| Minority's Interest | 0 | -15 | -17 | -19 | -21 | -32 | -34 | -37 | -36 | -36 | -38 |
| Borrowings | 294 | 28 | 249 | 246 | 159 | 77 | 0 | 0 | 2 | 2 | 1 |
| Other Non-Current Liabilities | 85 | 247 | 245 | 231 | 195 | 192 | 192 | 177 | 185 | 186 | 185 |
| Total Current Liabilities | 612 | 1437 | 1147 | 982 | 1023 | 1172 | 1322 | 1384 | 1472 | 362 | 363 |
| Total Liabilities | 227 | 1817 | 1659 | 1551 | 1374 | 1440 | 1475 | 1474 | 1572 | 1559 | 1542 |
| Fixed Assets | 125 | 1689 | 154 | 169 | 174 | 135 | 154 | 164 | 225 | 227 | 230 |
| Other Non-Current Assets | 6 | 8 | 4 | 8 | 8 | 6 | 6 | 8 | 8 | 11 | 7 |
| Total Current Assets | 95 | 120 | 1501 | 1373 | 1192 | 1300 | 1315 | 1302 | 363 | 345 | 327 |
| Total Assets | 227 | 1817 | 1659 | 1551 | 1374 | 1440 | 1475 | 1474 | 1572 | 1559 | 1542 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 13 | 5 | 5 | 76 | 31 | 24 | 33 | 22 | 7 | 1 | 1 |
| Cash Flow from Operating Activities | 46 | 59 | -451 | -160 | -81 | -50 | 10 | -13 | -66 | 631 | -70 |
| Cash Flow from Investing Activities | -6 | -0 | 343 | 112 | 164 | 8 | 11 | 7 | 56 | 10 | 12 |
| Cash Flow from Financing Activities | -48 | -59 | 179 | 3 | -90 | 52 | -32 | -10 | 6 | -642 | 58 |
| Net Cash Inflow / Outflow | -8 | 0 | 72 | -45 | -8 | 9 | -11 | -16 | -4 | -1 | -0 |
| Closing Cash & Cash Equivalent | 5 | 5 | 76 | 31 | 24 | 33 | 22 | 7 | 1 | 1 | 0 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -26.82 | -38.32 | -27.79 | 10.79 | -14.33 | 0.38 | -7.55 | -8.24 | -8.13 | 58.32 | -1.9 |
| CEPS(Rs) | -26.07 | -36.47 | -26.98 | 11.39 | -14.15 | -0.8 | -4.64 | -7.39 | -8.02 | 58.53 | -1.63 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | -153.95 | 17.72 | 5.1 | 16.48 | 2.57 | -137.19 | -144.68 | -152.55 | -153.54 | 9.73 | 7.61 |
| Core EBITDA Margin(%) | -75.9 | -86.89 | -60.76 | 5.33 | -17.76 | 6.44 | 0.19 | 1 | -0.14 | -16.07 | -3.06 |
| EBIT Margin(%) | -72.36 | -91.41 | -39.13 | 27.69 | -12.13 | 10.92 | 7.67 | 2.54 | 2.03 | 81.69 | 1.14 |
| Pre Tax Margin(%) | -115.33 | -146.45 | -66.98 | 14.33 | -29.52 | -2 | -7.45 | -8.05 | -7.86 | 73.69 | -2.42 |
| PAT Margin (%) | -115.33 | -146.45 | -66.98 | 14.33 | -29.52 | -2 | -7.45 | -8.05 | -7.86 | 73.07 | -2.25 |
| Cash Profit Margin (%) | -109.14 | -138.48 | -64.93 | 14.97 | -28.68 | -1.3 | -7.18 | -7.87 | -7.65 | 73.37 | -1.91 |
| ROA(%) | -71.39 | -25.39 | -10.76 | 4.56 | -6.69 | -0.59 | -2.22 | -3.45 | -3.63 | 25.01 | -0.83 |
| ROE(%) | 0 | 0 | -243.72 | 101.04 | -152.9 | 0 | 0 | 0 | 0 | 0 | -22.13 |
| ROCE(%) | 0 | -144.06 | -15.88 | 16.35 | -4.73 | 13.04 | 0 | 0 | 0 | 1204.99 | 2.16 |
| Receivable days | 38.31 | 18.23 | 11.17 | 11.03 | 19.4 | 7.09 | 5.2 | 8.1 | 10.2 | 12.42 | 7.92 |
| Inventory Days | 113.78 | 90.68 | 73.21 | 41.31 | 56.89 | 45.64 | 54.7 | 36.45 | 30.74 | 42.54 | 32.52 |
| Payable days | 666.21 | 875.83 | 463.05 | 183.81 | 121.01 | 49.06 | 40.73 | 34.23 | 40.11 | 36.59 | 13.66 |
| PER(x) | 0 | 0 | 0 | 2.13 | 0 | 105.2 | 0 | 0 | 0 | 0.73 | 0 |
| Price/Book(x) | -0.11 | 1.39 | 4.54 | 1.4 | 3.87 | -0.29 | -0.19 | -0.15 | -0.26 | 4.37 | 2.89 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 5.61 | 3.37 | 2.98 | 1.73 | 2.22 | 2.27 | 1.95 | 1.21 | 1.2 | 0.44 | 0.32 |
| EV/Core EBITDA(x) | -7.63 | -4.04 | -8.04 | 6.1 | -19.68 | 19.57 | 24.54 | 44.52 | 53.71 | -3.74 | 107.83 |
| Net Sales Growth(%) | -19.45 | 22.66 | 57.61 | 82.98 | -35.14 | 25.32 | 4.44 | 45.6 | 11.47 | -23.87 | 7.07 |
| EBIT Growth(%) | 29.35 | -39.47 | 32.53 | 229.48 | -128.4 | 212.82 | -26.58 | -51.85 | -11.05 | 2970.39 | -98.5 |
| PAT Growth(%) | 14.75 | -40.21 | 27.92 | 139.16 | -233.58 | 91.53 | -289.97 | -57.38 | -8.76 | 807.81 | -103.29 |
| EPS Growth(%) | 16.35 | -42.84 | 27.48 | 138.83 | -232.76 | 102.63 | -2103.37 | -9.1 | 1.29 | 817.23 | -103.25 |
| Debt/Equity(x) | -0.57 | 3.66 | 22.88 | 7.21 | 44.52 | -0.9 | -0.84 | -0.79 | -0.81 | 3.14 | 5.55 |
| Current Ratio(x) | 0.16 | 0.08 | 1.31 | 1.4 | 1.17 | 1.11 | 0.99 | 0.94 | 0.25 | 0.95 | 0.9 |
| Quick Ratio(x) | 0.09 | 0.05 | 1.25 | 1.34 | 1.12 | 1.06 | 0.94 | 0.91 | 0.2 | 0.8 | 0.78 |
| Interest Cover(x) | -1.68 | -1.66 | -1.41 | 2.07 | -0.7 | 0.85 | 0.51 | 0.24 | 0.2 | 10.21 | 0.32 |
| Total Debt/Mcap(x) | 3.88 | 2.64 | 5.05 | 5.17 | 11.58 | 3.1 | 4.34 | 5.42 | 3.16 | 0.72 | 1.92 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 58.78 | 58.78 | 58.78 | 58.78 | 58.78 | 58.78 | 58.78 | 58.78 | 58.78 | 58.78 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.41 | 0.41 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 41.21 | 41.21 | 41.21 | 41.21 | 41.21 | 41.21 | 41.21 | 41.21 | 40.79 | 40.79 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.03 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 2.77 | 2.77 | 2.77 | 2.77 | 2.77 | 2.77 | 2.77 | 2.77 | 2.74 | 2.74 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6.72 | 6.72 | 6.72 | 6.72 | 6.72 | 6.72 | 6.72 | 6.72 | 6.72 | 6.72 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +7% | -3% | +7% | +15% |
| Operating Profit CAGR | — | -51% | -47% | — |
| PAT CAGR | -103% | — | — | — |
| Share Price CAGR | +45% | +18% | +6% | +8% |
| ROE Average | -22% | -7% | -4% | -29% |
| ROCE Average | +2% | +402% | +241% | +97% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 58.78 | 58.78 | 58.78 | 58.78 | 58.78 | 58.78 | 58.78 | 58.78 | 58.78 | 58.78 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.41 | 0.41 |
| DII | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Public | 41.21 | 41.21 | 41.21 | 41.21 | 41.21 | 41.21 | 41.21 | 41.21 | 40.79 | 40.79 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 | 3.95 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.03 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 2.77 | 2.77 | 2.77 | 2.77 | 2.77 | 2.77 | 2.77 | 2.77 | 2.74 | 2.74 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6.72 | 6.72 | 6.72 | 6.72 | 6.72 | 6.72 | 6.72 | 6.72 | 6.72 | 6.72 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.